Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

112.21
+0.02000.02%
Post-market: 112.210.00000.00%19:50 EST
Volume:7.10M
Turnover:795.19M
Market Cap:195.12B
PE:30.16
High:112.64
Open:112.19
Low:111.18
Close:112.19
52wk High:141.23
52wk Low:105.27
Shares:1.74B
Float Shares:1.73B
Volume Ratio:0.87
T/O Rate:0.41%
Dividend:2.40
Dividend Rate:2.14%
EPS(TTM):3.72
EPS(LYR):3.73
ROE:13.16%
ROA:6.79%
PB:3.83
PE(LYR):30.08

Loading ...

BRIEF-Exact Sciences Stockholders Approve Acquisition By Abbott

Reuters
·
13 hours ago

Abbott Laboratories Streamlines Governance With Smaller Board

TIPRANKS
·
13 hours ago

Abbott Cuts Board Size to 12 Directors

Reuters
·
14 hours ago

Exact Sciences shareholders approve acquisition by Abbott

TIPRANKS
·
14 hours ago

Abbott posts FY 2025 COVID-19 testing-related sales of USD 297 million, down 60.2%

Reuters
·
14 hours ago

Exact Sciences Corp - Deal Expected to Close Before End of Q2 2026

THOMSON REUTERS
·
14 hours ago

Press Release: Exact Sciences Stockholders Approve Acquisition by Abbott

Dow Jones
·
14 hours ago

BTIG Sticks to Their Buy Rating for Abbott Laboratories (ABT)

TIPRANKS
·
18 hours ago

Abbott Keeps Quarterly Dividend at $0.63 a Share, Payable May 15 to Holders of Record as of April 15

MT Newswires Live
·
18 hours ago

Abbott Laboratories announces quarterly dividend of 63 cents per share dividend

Reuters
·
18 hours ago

Abbott - Declares Quarterly Dividend of 63 Cents per Share

THOMSON REUTERS
·
18 hours ago

Abbott Declares 409TH Consecutive Quarterly Dividend

THOMSON REUTERS
·
18 hours ago

Abitare In Publishes Minutes of January 21 Shareholders’ Meeting

TIPRANKS
·
Yesterday

BTIG Adjusts Price Target on Abbott Laboratories to $140 From $145, Maintains Buy Rating

MT Newswires Live
·
Feb 17

Medtronic beats quarterly profit estimates on robust demand for heart devices

Reuters
·
Feb 17

RFK Jr.'s Next Overhaul: America's Baby Formula Guidelines -- WSJ

Dow Jones
·
Feb 17

ICICI Securities Remains a Buy on Abbott India Limited (ABBOTINDIA)

TIPRANKS
·
Feb 16

Exact Sciences Faces Rising Operational Risk and Strategic Constraints Amid Pending Abbott Merger

TIPRANKS
·
Feb 15

Kepler Capital Keeps Their Buy Rating on Fielmann (0MG1)

TIPRANKS
·
Feb 15

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Abbott Laboratories (ABT)

TIPRANKS
·
Feb 14